Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,231
Total Claims
$5.1M
Drug Cost
690
Beneficiaries
$7,428
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+403%
Opioid rate vs peers
6.6% vs 1.3% avg
+84%
Cost per patient vs peers
$7,428 vs $4,034 avg
+4%
Brand preference vs peers
9.8% vs 9.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 403% above Neurology peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
6.6%
Opioid Rate
607
Opioid Claims
$19K
Opioid Cost
5.1%
Long-Acting Rate
Brand vs Generic
Brand: 900 claims · $3.7M
Generic: 8,264 claims · $1.5M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tasimelteon | 34 | $712K |
| Tasimelteon | 19 | $489K |
| Interferon Beta-1a/Albumin | 16 | $264K |
| Teriflunomide | 22 | $259K |
| Valbenazine Tosylate | 30 | $239K |
| Pimavanserin Tartrate | 33 | $185K |
| Fingolimod Hcl | 18 | $152K |
| Eslicarbazepine Acetate | 63 | $109K |
| Everolimus | 11 | $86K |
| Atogepant | 70 | $79K |
| Dextromethorphan Hbr/Quinidine | 43 | $67K |
| Cenobamate | 29 | $66K |
| Rimegepant Sulfate | 42 | $59K |
| Amantadine Hcl | 15 | $50K |
| Rotigotine | 42 | $42K |
Prescribing Profile
131
Unique Drugs
24.0
Anomaly Score
Patient Profile
69
Avg Age
65%
Female
1.49
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About